Did the company provide revised guidance for FY 2025, and how does it compare to prior guidance and consensus expectations?

Answer

Based on the press‑release excerpt you supplied (the Addus HomeCare Q2 2025 results announced on 4 August 2025), the company did not disclose any revised guidance for fiscal 2025. The release focuses on the second‑quarter and six‑month operating performance—highlighting net service‑revenue growth, net income, adjusted net income per diluted share, adjusted EBITDA, and cash‑flow metrics—but it does not contain a section that:

1. Provides a new FY 2025 revenue, earnings‑per‑share, or EBITDA outlook (i.e., a “revised guidance”).
2. References the prior FY 2025 guidance that might have been issued in earlier quarters or at the end of 2024.
3. Mentions analyst consensus expectations for FY 2025 (e.g., the Street’s average estimate for revenue, EPS, or adjusted EBITDA).

Because none of those elements appear in the provided text, we cannot:

• Compare any revised FY 2025 guidance to the company’s earlier guidance (since no revised numbers are given).
• Contrast the company’s guidance with consensus expectations (since the consensus figures are not cited in the release).

What this means for investors or analysts

• No updated outlook: Until Addus HomeCare issues a separate communication (e.g., a “Guidance Update” press release, a conference‑call transcript, or a filing with the SEC) that includes revised FY 2025 targets, the market will continue to rely on the most recent guidance that was previously provided (if any) and on analyst forecasts.
• Potential follow‑up: Companies often issue guidance updates after a strong quarter—especially when results beat prior expectations. Given the robust Q2 performance (net service‑revenue up 21.8 % to $349.4 M, net income of $22.1 M, adjusted EBITDA up 24.5 % to $43.9 M), it would be reasonable for analysts to expect that Addus may raise its FY 2025 outlook in a later communication. However, without an explicit statement in this release, any such expectation remains speculative.
• Action for stakeholders: If you need the revised FY 2025 guidance, you should monitor:
  • Subsequent Addus HomeCare press releases (often posted on the company’s investor‑relations website).
  • SEC filings (e.g., Form 8‑K) that accompany earnings releases.
  • Company conference‑call transcripts (the Q2 earnings call may include a “Management Discussion & Outlook” segment where guidance is addressed).
  • Analyst research updates (e.g., Bloomberg, FactSet, or Thomson Reuters) that capture any new guidance once it is publicly disclosed.

Bottom line: The information you provided does not include revised FY 2025 guidance, nor does it compare any new guidance to prior guidance or consensus expectations. To obtain those details, you’ll need to locate a later Addus HomeCare communication that specifically addresses FY 2025 outlook.